mkc253
Peptideexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2007 (NCT00475371)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
GLP1R agonist
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- glp-1 (7-36)amide
- glp-1-(7-36) amide
- glp-1a
- glp-i (7-36)amide
- glp-i (7-36)nh2
- glucagon-like peptide 1 (7-36)amide
- glucagon-like peptide-1(7-36 amide)
- glucagon-like peptide i (7-36)amide
- mkc253
- mkc253
- mkc253
- mkc 253
- mkc-253
- proglucagon (78-107) amide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00642538 | Phase 1 | Feb 1, 2008 | MannKind Corp |
| NCT00475371 | Phase 1 | Apr 1, 2007 | MannKind Corp |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MannKind Corp | For profit | 2 | 2 | 1 | 2007 |
1 organizations
Page 1 / 1